Skip to main content
Earnings Labs
LENZ Therapeutics, Inc. logo

LENZ Therapeutics, Inc. (LENZ)

NASDAQ·Healthcare·Biotechnology

$4.95

-0.90%

Mkt Cap $166.18M

Analyst Ratings

Buy

6

Hold

1

Sell

0

Price Target (6 analysts)

$12.00

Range $12.00$12.00

Implied Upside

+142.4%

Consensus $12.00 vs current $4.95